4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-022894
CEO sold 55,684 shares at $3.09 ($171,841)
- CEO acquired 76,490 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-21 | Exercise or conversion : show line 1 in the form | +76,490 | $1.69 | $129,345 | 1,117,408 | D |
| 2026-05-21 | Sale : show line 2 in the form | −55,684 | $3.09 | $171,841 | 1,061,724 | D |
| Open-market sales · 55,684 sh · avg $3.09 · $171,841 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-21 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −76,490 | $1.69 | $129,345 | 0 | D |
Loading xslF345X06/form4.xml…